Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-14

FDA Approved: COLCHICINE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for colchicine submitted by Par Health USA, LLC. The action pertains to the generic colchicine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

SUPPL AP for COLCHICINE (COLCHICINE)